Developments in pharmacological therapy for the overactive bladder

被引：9
作者：
Chapple, Christopher R.
Gormley, E. Ann
机构：
[1] Sheffield Hallam Univ, Dept Urol, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield 510 2JF, S Yorkshire, England
[2] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH USA
来源：
BJU INTERNATIONAL | 2006年 / 98卷
关键词：
overactive bladder; pharmacotherapy; detrusor overactivity; cholinergic-muscarinic receptors; adrenoceptor; agonist; antagonist; anticholinergics; vanilloids; botulinum toxin; RAT URINARY-BLADDER; QUALITY-OF-LIFE; DETRUSOR SMOOTH-MUSCLE; ANTIMUSCARINIC AGENT SOLIFENACIN; SELECTIVE RECEPTOR ANTAGONIST; EXTENDED-RELEASE FORMULATIONS; CARBACHOL-INDUCED CONTRACTION; BOTULINUM-TOXIN; CONTROLLED TRIAL; AUTONOMOUS ACTIVITY;
D O I：
10.1111/j.1464-410X.2006.06381.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：78 / 87
页数：10
相关论文
共 96 条
[81]   Electrical characteristics of suburothelial cells isolated from the human bladder [J].
Sui, GP ;
Wu, C ;
Fry, CH .
JOURNAL OF UROLOGY, 2004, 171 (02) :938-943
[82]   Gap junctions and connexin expression in human suburothelial interstitial cells [J].
Sui, GP ;
Rothery, S ;
Dupont, E ;
Fry, CH ;
Severs, NJ .
BJU INTERNATIONAL, 2002, 90 (01) :118-129
[83]   THE VANILLOID (CAPSAICIN) RECEPTOR - RECEPTOR TYPES AND SPECIES-DIFFERENCES [J].
SZALLASI, A .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1994, 25 (02) :223-243
[84]   Vanilloid receptors: New insights enhance potential as a therapeutic target [J].
Szallasi, A ;
Blumberg, PM .
PAIN, 1996, 68 (2-3) :195-208
[85]   Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig [J].
Templeman, L ;
Chapple, CR ;
Chess-Williams, R .
JOURNAL OF UROLOGY, 2002, 167 (02) :742-745
[86]   THE INFLUENCE OF BETA-ADRENOCEPTOR AND MUSCARINIC RECEPTOR AGONISTS AND ANTAGONISTS ON THE STATIC URETHRAL CLOSURE FUNCTION IN HEALTHY FEMALES [J].
THIND, P ;
LOSE, G ;
COLSTRUP, H ;
ANDERSSON, KE .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1993, 27 (01) :31-38
[87]   Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system [J].
Todorova, A ;
Vonderheid-Guth, B ;
Dimpfel, W .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (06) :636-644
[88]   Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder [J].
Van Kerrebroeck, P ;
Kreder, K ;
Jonas, U ;
Zinner, N ;
Wein, AN .
UROLOGY, 2001, 57 (03) :414-421
[89]  
WANG P, 1995, J PHARMACOL EXP THER, V273, P959
[90]  
WEIN A, 2002, CAMPBELLS UROLOGY, V2
12345678910